Anatomic Pathology Industry Overview:
The anatomic pathology market is projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a CAGR of 7.0%. The growth of the anatomical pathology market is primarily driven by the high incidence of cancer and other target diseases, cancer screening recommendations, reimbursement possibilities, and growing interest in personalized medicine.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Anatomic pathology products and services are used in oncology drug trials to analyze quantitative information, detect morphological structures, detect pharmacodynamic markers, and understand drug mechanisms. It is also used to stratify trial subjects based on the responses given by tissues to the drugs.
Globally, the COVID-19 outbreak has impacted every aspect of the diagnostics industry, including the anatomic pathology industry. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals.
Anatomic Pathology Services segment accounted for the largest share of the global anatomic pathology market
Based on product & service, the anatomic pathology market is segmented into services, consumables, and instruments. The services segment accounted for the largest market share
By Application, disease diagnostics accounted for the largest market share
Based on application, the anatomic pathology market is segmented into disease diagnostics and medical research. The disease diagnostics segment accounted for a larger share of the market.
By End User, Hospital laboratories accounted for the largest market share
Based on end user, the anatomic pathology market is segmented into hospital laboratories, clinical laboratories, and other end users. Hospital laboratories accounted for the largest share.
North America dominates the anatomic pathology market
North America accounted for the largest share of the anatomic pathology market. Factors such as the rising prevalence of chronic diseases, increasing healthcare expenditure, the high-quality infrastructure for hospitals and clinical laboratories, and the presence of major market players in the region are driving the growth of the anatomic pathology market in North America.
Some prominent players in the global anatomic pathology market Include:
The major players in the anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC Holdings Corporation (Japan).
Anatomic Pathology Market Segmentation
MarketsandMarkets has segmented the Anatomic Pathology Market based on Product Type, End User application, and region:
By Product and Service
By End User